Showing 921 - 940 results of 104,475 for search '(( 5 ((((ppm decrease) OR (a decrease))) OR (mean decrease)) ) OR ( i wt decrease ))', query time: 1.62s Refine Results
  1. 921
  2. 922
  3. 923
  4. 924

    Galiellalactone decreases the proportion of ALDH+ prostate cancer cells in vitro and the ALDH1A1 expression in vivo. by Rebecka Hellsten (348459)

    Published 2013
    “…<p>A. DU145 and LNCaP-IL6 cells were treated with galiellalactone (5–50 µM) for 24 h and subjected to ALDEFLUOR® assay. …”
  5. 925
  6. 926
  7. 927
  8. 928
  9. 929
  10. 930
  11. 931
  12. 932
  13. 933

    Severe decreases of TECs and impaired TEC expansion in the absence of mTORC1/Raptor. by Hong-Xia Wang (288934)

    Published 2016
    “…Each circle or square represents one WT or <i>Rpt</i><sup><i>f/f</i></sup><i>-Foxn1Cre</i> mouse, respectively. *, <i>p</i> < 0.05; **, <i>p</i> < 0.01; ***, <i>p</i> < 0.001 determined by two-tail Student’s <i>t</i> test.…”
  14. 934
  15. 935
  16. 936
  17. 937

    Tunicamycin produces a concentration- and time-dependent decrease in cell viability in SH-SY5Y cells concomitant with caspase-3 activation. by Arindam P. Ghosh (317870)

    Published 2013
    “…<p>(A) Treatment of SH-SY5Y cells with tunicamycin (0.1–5µM) for 24 h caused a progressive decrease in cell viability as measured by Calcein AM cleavage assay. …”
  18. 938
  19. 939
  20. 940

    The novel <i>carboxylesterase 1</i> variant c.662A>G may decrease the bioactivation of oseltamivir in humans by Jaeseong Oh (3947381)

    Published 2017
    “…A novel <i>CES1</i> c.662A>G single nucleotide polymorphism (SNP) was predicted to decrease CES1 enzymatic activity in an <i>in silico</i> analysis. …”